Giulia Landini
University of Siena
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Giulia Landini.
Nanomedicine: Nanotechnology, Biology and Medicine | 2015
Emanuele Cavaliere; Sebastiano De Cesari; Giulia Landini; Eleonora Riccobono; Lucia Pallecchi; Gian Maria Rossolini; Luca Gavioli
UNLABELLED The recent emergence of bacterial pathogens resistant to most or all available antibiotics is among the major global public health problems. As indirect transmission through contaminated surfaces is a main route of dissemination for most of such pathogens, the implementation of effective antimicrobial surfaces has been advocated as a promising approach for their containment, especially in the hospital settings. However, traditional wet synthesis methods of nanoparticle-based antimicrobial materials leave a number of key points open for metal surfaces: such as adhesion to the surface and nanoparticle coalescence. Here we demonstrate an alternative route, i.e. supersonic cluster beam deposition, to obtain antimicrobial Ag nanoparticle films deposited directly on surfaces. The synthesized films are simple to produce with controlled density and thickness, are stable over time, and are shown to be highly bactericidal against major Gram positive and Gram negative bacterial pathogens, including extensively drug-resistant strains. FROM THE CLINICAL EDITOR The use of silver nanoparticle in health care is getting more widespread. The authors here describe the technique of cluster beam deposition for spraying silver on surfaces used in health care sectors. This may open a new avenue for future anti-bacterial coatings.
International Journal of Antimicrobial Agents | 2015
Giulia Landini; Eleonora Riccobono; Tommaso Giani; Fabio Arena; Gian Maria Rossolini; Lucia Pallecchi
between the combination of antibiotics and the single most effective antibiotic was used as the cut-off for synergy. In the time-kill experiments, penicillin and gentamicin had a synergistic bactericidal effect, at one or more concentrations or time points, against 14 (58%) of the 24 isolates (see Table 1). For many isolates, synEthical approval to use the data from the Swedish Endocarditis registry was obtained from the regional ethics review board [ref. no. 2013/182].
Journal of Antimicrobial Chemotherapy | 2016
Costas C. Papagiannitsis; Vincenzo Di Pilato; Tommaso Giani; Panagiota Giakkoupi; Eleonora Riccobono; Giulia Landini; Vivi Miriagou; Alkiviadis Vatopoulos; Gian Maria Rossolini
OBJECTIVES Global dissemination of KPC-type carbapenemases is mainly associated with the spread of high-risk clones of Klebsiella pneumoniae and of KPC-encoding plasmids. In this study, we explored the population structure of KPC-encoding plasmids from the recent epidemics of KPC-producing K. pneumoniae (KPC-Kp) in Greece and Italy, the two major European endemic settings. METHODS Thirty-four non-replicate clinical strains of KPC-Kp representative of the early phases (2008-11) of the Greek (n = 22) and Italian (n = 12) epidemics were studied. Isolates were typed by MLST, and blaKPC-carrying plasmids were characterized by S1 profiling, PCR-based replicon typing and RFLP. Transfer experiments by conjugation or transformation were carried out with Escherichia coli recipients. Eleven plasmids, representative of all different restriction profiles, were completely sequenced. RESULTS The representative Greek strains belonged to 14 sequence types (STs), with a predominance of ST258. The representative Italian strains belonged to three STs, with a predominance of clonal complex 258 (ST258, ST512). The 34 strains carried plasmids of variable size (78-166 kb), either with blaKPC-2 or blaKPC-3 gene embedded in a Tn4401a transposon. Plasmids from Greek strains were mostly of a single RFLP type (A) and resembled the archetypal pKpQIL KPC-encoding plasmid, while plasmids from Italian strains belonged to a more heterogeneous population, showing five RFLP profiles (A, C-F). Types A and C resembled pKpQIL or deletion derivatives thereof, while types D-F included plasmids with hybrid structures between pKpQIL, pKPN3 and pKPN101-IT. CONCLUSIONS pKpQIL-like plasmids played a major role in the dissemination of blaKPC in Greece and Italy, but evolved with different dynamics in these endemic settings.
APL Materials | 2017
Giulio Benetti; Emanuele Cavaliere; Adalberto Canteri; Giulia Landini; Gian Maria Rossolini; Lucia Pallecchi; Mirco Chiodi; Margriet Van Bael; Naomi Winckelmans; Sara Bals; Luca Gavioli
Ultrathin coatings based on bi-elemental nanoparticles (NPs) are very promising to limit the surface-related spread of bacterial pathogens, particularly in nosocomial environments. However, tailoring the synthesis, composition, adhesion to substrate, and antimicrobial spectrum of the coating is an open challenge. Herein, we report on a radically new nanostructured coating, obtained by a one-step gas-phase deposition technique, and composed of bi-elemental Janus type Ag/Ti NPs. The NPs are characterized by a cluster-in-cluster mixing phase with metallic Ag nano-crystals embedded in amorphous TiO2 and present a promising antimicrobial activity including also multidrug resistant strains. We demonstrate the flexibility of the method to tune the embedded Ag nano-crystals dimension, the total relative composition of the coating, and the substrate type, opening the possibility of tailoring the dimension, composition, antimicrobial spectrum, and other physical/chemical properties of such multi-elemental systems. ...
Antimicrobial Agents and Chemotherapy | 2016
Giulia Landini; Tiziana Di Maggio; Francesco Sergio; Jean Denis Docquier; Gian Maria Rossolini; Lucia Pallecchi
ABSTRACT The effect of high N-acetylcysteine (NAC) concentrations (10 and 50 mM) on antibiotic activity against 40 strains of respiratory pathogens was investigated. NAC compromised the activity of carbapenems (of mostly imipenem and, to lesser extents, meropenem and ertapenem) in a dose-dependent fashion. We demonstrated chemical instability of carbapenems in the presence of NAC. With other antibiotics, 10 mM NAC had no major effects, while 50 mM NAC sporadically decreased (ceftriaxone and aminoglycosides) or increased (penicillins) antibiotic activity.
PLOS ONE | 2018
Simona Pollini; Vincenzo Di Pilato; Giulia Landini; Tiziana Di Maggio; Antonio Cannatelli; Samantha Sottotetti; Lisa Cariani; Stefano Aliberti; Francesco Blasi; Francesco Sergio; Gian Maria Rossolini; Lucia Pallecchi
Stenotrophomonas maltophilia and Burkholderia cepacia complex (Bcc) have been increasingly recognized as relevant pathogens in hospitalized, immunocompromised and cystic fibrosis (CF) patients. As a result of complex mechanisms, including biofilm formation and multidrug resistance phenotype, S. maltophilia and Bcc respiratory infections are often refractory to therapy, and have been associated with a worse outcome in CF patients. Here we demonstrate for the first time that N-acetylcysteine (NAC), a mucolytic agent with antioxidant and anti-inflammatory properties, may exhibit antimicrobial and antibiofilm activity against these pathogens. The antimicrobial and antibiofilm activity of high NAC concentrations, potentially achievable by topical administration, was tested against a collection of S. maltophilia (n = 19) and Bcc (n = 19) strains, including strains from CF patients with acquired resistance traits. Minimum Inhibitory Concentrations (MICs) and Minimum Bactericidal Concentrations (MBCs) ranged from 16 to 32 mg/ml and from 32 to >32 mg/ml, respectively. Sub-MIC concentrations (i.e., 0.25 × MIC) slowed down the growth kinetics of most strains. In time-kill assays, 2-day-old biofilms were more affected than planktonic cultures, suggesting a specific antibiofilm activity of NAC against these pathogens. Indeed, a dose- and time-dependent antibiofilm activity of NAC against most of the S. maltophilia and Bcc strains tested was observed, with a sizable antibiofilm activity observed also at 0.5 and 1 × MIC NAC concentrations. Furthermore, at those concentrations, NAC was also shown to significantly inhibit biofilm formation with the great majority of tested strains.
Lasers in Medical Science | 2017
Marco Giannelli; Giulia Landini; Fabrizio Materassi; Flaminia Chellini; Alberto Antonelli; Alessia Tani; Daniele Nosi; Sandra Zecchi-Orlandini; Gian Maria Rossolini; Daniele Bani
Lasers in Medical Science | 2016
Marco Giannelli; Giulia Landini; Fabrizio Materassi; Flaminia Chellini; Alberto Antonelli; Alessia Tani; Sandra Zecchi-Orlandini; Gian Maria Rossolini; Daniele Bani
European Respiratory Journal | 2017
Francesco Sergio; Lucia Pallecchi; Giulia Landini; Tiziana Di Maggio; Lisa Cariani; Francesco Blasi; Gian Maria Rossolini
European Respiratory Journal | 2017
Francesco Sergio; Lucia Pallecchi; Giulia Landini; Tiziana Di Maggio; Samantha Sottotetti; Lisa Cariani; Francesco Blasi; Gianmaria Rossolini
Collaboration
Dive into the Giulia Landini's collaboration.
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
View shared research outputs